(As part of pharmacovigilance): the analysis and prioritisation of signals of new risks or risks that have changed or changes to the risk-benefit balance of a medicine.
(As part of pharmacovigilance): the analysis and prioritisation of signals of new risks or risks that have changed or changes to the risk-benefit balance of a medicine.
Use our tool to look up the definition of terms in our glossary.
©2023 Trilogy Writing & Consulting GmbH | Impressum (Legal Information & Cookie Policy)